Detection of influenza A viruses from different species by PCR amplification of conserved sequences in the matrix gene by Fouchier, R.A.M. (Ron) et al.
JOURNAL OF CLINICAL MICROBIOLOGY,
0095-1137/00/$04.0010
Nov. 2000, p. 4096–4101 Vol. 38, No. 11
Copyright © 2000, American Society for Microbiology. All Rights Reserved.
Detection of Influenza A Viruses from Different Species by PCR
Amplification of Conserved Sequences in the Matrix Gene
RON A. M. FOUCHIER,* THEO M. BESTEBROER, SANDER HERFST, LIANE VAN DER KEMP,
GUUS F. RIMMELZWAAN, AND ALBERT D. M. E. OSTERHAUS
National Influenza Center and Department of Virology, Erasmus University, Rotterdam, The Netherlands
Received 11 May 2000/Returned for modification 27 July 2000/Accepted 5 September 2000
The recently raised awareness of the threat of a new influenza pandemic has stimulated interest in the
detection of influenza A viruses in human as well as animal secretions. Virus isolation alone is unsatisfactory
for this purpose because of its inherent limited sensitivity and the lack of host cells that are universally
permissive to all influenza A viruses. Previously described PCR methods are more sensitive but are targeted
predominantly at virus strains currently circulating in humans, since the sequences of the primer sets display
considerable numbers of mismatches to the sequences of animal influenza A viruses. Therefore, a new set of
primers, based on highly conserved regions of the matrix gene, was designed for single-tube reverse transcrip-
tion-PCR for the detection of influenza A viruses from multiple species. This PCR proved to be fully reactive
with a panel of 25 genetically diverse virus isolates that were obtained from birds, humans, pigs, horses, and
seals and that included all known subtypes of influenza A virus. It was not reactive with the 11 other RNA
viruses tested. Comparative tests with throat swab samples from humans and fecal and cloacal swab samples
from birds confirmed that the new PCR is faster and up to 100-fold more sensitive than classical virus isolation
procedures.
Migratory birds and waterfowl are thought to serve as the
reservoir for influenza A viruses in nature (24). To date, influ-
enza A viruses representing 15 hemagglutinin (HA) and nine
neuraminidase (NA) subtypes have been detected in wild birds
and poultry throughout the world (19, 24). Since the general
human population is serologically naive with respect to most
avian HA and NA antigens, influenza A viruses of avian origin
pose a threat that is at the basis of new pandemics in humans
(4, 24). For some time it was thought that avian influenza
viruses could be transmitted to humans only through coinfec-
tion and genetic reassortment of avian and swine or human
influenza viruses in pigs (4, 13, 22, 24, 25). However, the recent
zoonotic events in Hong Kong and mainland China caused by
H5N1 and H9N2 influenza viruses suggest that avian influenza
viruses can be transmitted directly to humans as well (5, 8–10,
15). The link between human influenza and the avian influenza
virus reservoir has boosted the public health-related and sci-
entific interest in the prevalence, variability, and zoonotic po-
tential of avian influenza viruses.
Although the routine procedures for the detection of human
influenza A viruses described to date, including in vitro virus
isolation, immunofluorescence (IF), and PCR-based assays,
are powerful tools, they may be less effective for the detection
of influenza viruses of avian and porcine origin. The pheno-
typic and genetic heterogeneities of the latter viruses may
result in a false-negative diagnosis of influenza A virus infec-
tion by in vitro cell culture or current protocols for PCR anal-
ysis. Importantly, sporadic zoonotic events of influenza A virus
infection may remain undetected as a result of such false-
negative diagnoses.
The aim of this study was to set up a rapid and sensitive PCR
method for the screening of clinical specimens for the presence
of phenotypically and genotypically diverse influenza A viruses.
To this end, we have designed a primer set for PCR-based
detection of influenza A viruses that was validated with clinical
specimens and a panel of influenza A virus strains representing
all known HA and NA subtypes obtained from a variety of host
species and from different geographical locations. The efficacy
of this PCR-based screening of samples from avian and human
origin was compared with classical isolation of influenza A
virus in embryonated chicken eggs or mammalian cell culture.
We conclude that this PCR, based on the detection of gene
segment 7 of influenza A virus, is fast, sensitive, and specific
and is suitable for all genetic variants of influenza A virus
known to date.
MATERIALS AND METHODS
Design of oligonucleotides. PCR primers were designed on the basis of se-
quence information obtained from the Influenza Sequence Database at Los
Alamos National Laboratories, Los Alamos, N.M. (http://www.flu.lanl.gov). To
identify conserved sequences in the influenza virus gene segments, entropy plots
were created with the Bioedit software package (available through http:
//www.mbio.ncsu.edu/RNaseP/info/programs/BIOEDIT/bioedit.html). Because
the HA and NA genes are genetically diverse and sequence information on the
PA, PB1, and PB2 polymerase genes is limited (less than 100 sequence entries
are available from the database, including partial sequences) only (partial) se-
quences representing gene segments 5, 7, and 8 encoding nucleoprotein, matrix,
and nonstructural proteins, respectively, were analyzed. The degree of hetero-
geneity was expressed as entropy as defined by Shannon: H (1) 5 2Sf(b, 1) ln
[f(b, 1)], where H (1) is the uncertainty at position 1, b represents a residue out
of the allowed choices for the sequence in question (A, C, G, T, 2), and f(b, 1)
is the frequency at which residue b is found at position 1 (16, 21). Oligonu-
cleotides M52C (59-CTT CTA ACC GAG GTC GAA ACG-39) and M253R
(59-AGG GCA TTT TGG ACA AAG/T CGT CTA-39) were designed for PCR
amplification of influenza A virus matrix gene sequences, and the biotinylated
oligonucleotide Bio-M93C (59-CCG TCA GGC CCC CTC AAA GCC GA-39)
was synthesized for hybridization purposes (Eurogentec, Seraing, Belgium).
Specimens. Cloacal swab specimens were collected from ducks (widgeon
[Mareca penelope], gadwall [Mareca strepera], and mallard [Anas plathyrhynchos])
at a marshaling lake in Lekkerkerk, The Netherlands, and droppings as well as
cloacal swab specimens were collected from geese (greylag goose [Anser anser],
white-fronted goose [Anser albifrons albifrons], barnacle goose [Branta leucopsis],
and brent goose [Branta bernicla]) in Groningen and Eemdijk, The Netherlands,
between 1997 and 1999. Cloacal swab specimens and droppings were collected
from shorebirds at O¨land, Sweden, in the spring of 1999. Cotton swabs were used
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for sampling and were subsequently stored in transport medium (23). Throat
swab specimens collected from humans were also stored in transport medium.
The samples were stored at 4°C for a few days, at 220°C for less than a week, or
at 270°C for extended periods of time. Transport medium consisted of Hanks
balanced salt solution supplemented with 10% glycerol, 200 U of penicillin per
ml, 200 mg of streptomycin per ml, 100 U of polymyxin B sulfate per ml, 250 mg
of gentamicin per ml, and 50 U of nystatin per ml (all from ICN, Zoetermeer,
The Netherlands).
RNA isolation. RNA was isolated with a high pure RNA isolation kit (Roche
Molecular Biochemicals) according to the instructions from the manufacturer,
with minor modifications. A 0.2-ml sample was homogenized by vortexing and
was subsequently lysed with 0.4 ml of lysis-binding buffer to which poly(A)
(Roche Molecular Biochemicals) was added as a carrier to 1 mg/ml. After binding
to the column, DNase I digestion, and washing, the RNA was eluted in 50 ml of
nuclease-free double-distilled water preheated to 80°C.
PCR. The reverse transcription (RT) and PCRs were optimized with respect to
enzymes, primer sets, and concentrations of reagents as well as cycling param-
eters. Samples were amplified in a one-step RT-PCR in a final volume of 25 ml
containing 50 mM Tris z HCl (pH 8.5), 50 mM NaCl, 7 mM MgCl2, 2 mM
dithiothreitol, 1 mM each deoxynucleoside triphosphate at a concentration of 1
mM, each oligonucleotide at a concentration of 0.4 mM, 2.5 U of recombinant
RNAsin, 10 U of avian myeloblastosis virus reverse transcriptase, 2.5 U of
Ampli-Taq DNA polymerase (all enzymes were from Promega Benelux B.V.,
Leiden, The Netherlands), and 5 ml of RNA. Thermocycling was performed in an
MJ PTC-200 apparatus with the following cycling conditions: 30 min at 42°C and
4 min at 95°C once and then 1 min at 95°C, 1 min at 45°C, 3 min at 72°C 40 times.
Each reaction was analyzed by agarose gel electrophoresis and ethidium bromide
staining (10 ml/sample), followed by Southern blot hybridization (2) or dot blot
hybridization (5 ml/sample).
Dot blot hybridization. Five microliters of each of the PCR products was
incubated for 5 min at room temperature with 45 ml of 10 mM Tris z HCl (pH
8.0), 1 mM EDTA, and 50 ml of 1 M NaOH for denaturation. The samples were
transferred to prewetted Hybond N1 membranes (Amersham Pharmacia Bio-
tech Benelux, Roosendaal, The Netherlands) with a dot blot apparatus while
applying vacuum. The samples were then treated for 3 min with 0.1 ml of 1 M
Tris z HCl (pH 8.0), after which vacuum was again applied for 10 s and the
membrane was removed from the apparatus. The blots were washed three times
for 10 min each time with 0.3 M NaCl–30 mM sodium citrate (pH 7), dried, and
stored at 4°C. The blots were prehybridized for 5 min at 55°C in 23 SSPE (0.3
M NaCl, 20 mM NaH2PO4, 2 mM EDTA [pH 7.4]) and 0.1% sodium dodecyl
sulfate (SDS), after which biotinylated oligonucleotide probe Bio-M93C was
added to 2 pmol/ml and hybridization was continued for 45 min at 55°C. The
blots were washed twice for 10 min each time at 55°C with hybridization buffer
and transferred to 23 SSPE with 0.5% SDS, after which streptavidin-peroxidase
(Roche Molecular Biochemicals) was added to 0.125 U/ml and the mixture was
incubated for 45 min at 42°C. The blots were washed for 10 min at 42°C in 23
SSPE–0.5% SDS, 10 min at 42°C in 23 SSPE–0.1% SDS, and 10 min at room
temperature in 23 SSPE, after which the samples were visualized with enhanced
chemiluminescence detection reagents and by exposure to hyperfilm (Amersham
Pharmacia Biotech Benelux) for 5 to 60 s.
Virus isolation and propagation. The influenza A viruses listed in Table 1 have
been described earlier and were kindly provided by R. G. Webster (14, 19). All
of these viruses had been isolated and propagated in the allantoic cavities of
11-day-old embryonated chicken eggs (12). Influenza virus A/Netherlands/18/94
has been described previously (18). Influenza A virus strains not listed in Table
1 were isolated and propagated in Madin-Darby canine kidney (MDCK) cells or
tertiary monkey kidney (tMK) cells derived from cynomolgus macaques (Macaca
fascicularis) (7, 17). Virus stocks were titrated by end point dilution in MDCK or
tMK cells, and the 50% tissue culture infective doses (TCID50s) were calculated
as described previously (17). The HA titers in the virus stocks were determined
with turkey erythrocytes by standard procedures (17). Virus isolates were char-
acterized by hemagglutination inhibition assays with subtype-specific hyperim-
mune rabbit antisera raised against HA and NA preparations of the virus isolates
listed in Table 1 (20).
Human respiratory syncytial virus (HRSV) was grown in HEp-2 cells, mumps
and measles viruses were grown in Vero cells, human parainfluenza virus (PIV)
types 1 through 4 (PIV-1 through PIV-4) and influenza B virus were grown in
tMK cells, and Sendai virus, simian parainfluenza virus type 5 (SV5), and New-
castle disease virus (NDV) were grown in embryonated chicken eggs. The virus
titers of these stocks typically ranged from 104 to 106 TCID50s/ml.
RESULTS
Design of oligonucleotides for PCR detection of influenza A
viruses. Avian and mammalian influenza A virus nucleotide
sequences available from the influenza sequence database
(http://www.flu.lanl.gov) were compared to the sequences of
previously described primer sets Mx1 and Mx2 (3), Fam1 and
Fam2 (1), and NS486C and NS637R (6, 7) to analyze their
potential for the detection of genetically diverse influenza A
viruses. The variability between the influenza A virus nucleo-
tide sequences and each position in the potential PCR primers
was calculated by using the entropy algorithm available from
the Bioedit software package (16, 21). Although each of the
primer sequences was based on a relatively conserved domain
of gene segments 7 and 8 of influenza A virus, considerable
heterogeneity was observed for each of the oligonucleotide sets
(Fig. 1). The 39 ends of oligonucleotides are of the greatest
importance for the successful amplification by PCR. Of all
three published primer sets (Fig. 1A to F), at least one of the
oligonucleotides displayed considerable numbers of mis-
matches with the sequences in the database. Since such mis-
matches may lead to false-negative PCR results, we designed
new primer sets based on segment 7 of influenza A virus, which
is relatively conserved compared to the other segments. Within
the M1 coding sequence of gene segment 7, several regions
(positions 32 to 93, 149 to 204, and 218 to 276) were identified
that are relatively conserved among influenza A virus strains
obtained from a variety of host species and from different
geographical regions. Oligonucleotides M52C (nucleotide po-
sitions 32 to 52), M93C (positions 71 to 93), and M253R
(positions 253 to 276) (Fig. 1) were designed on the basis of
these conserved regions of the influenza A virus genome. Al-
though other conserved regions were identified in the NS2
coding sequence of gene segment 8 and the M1 coding se-
quence of segment 7, we found primers based on these se-
quences to be less suitable for PCR amplification of selected
influenza A virus strains (data not shown).
Sensitivity and specificity of influenza A virus PCR. RNA
was isolated from 0.2 ml of allantoic fluid containing the in-
fluenza A viruses shown in Table 1, and the equivalent of 4 ml
of allantoic fluid was used for amplification by PCR with
primer set M52C-M253R. For each of the virus strains tested,
a band of 244 bp was amplified and was easily visualized on a
1% agarose gel stained with ethidium bromide (Fig. 2). Hy-
TABLE 1. Virus isolates used for the validation of PCR-based
detection of influenza A virus
Influenza A virus strain HAsubtype
NA
subtype
HA
titer
Lane no.
(Fig. 2)
A/Puerto Rico/8/34 1 1 384 1
A/Fort Monmouth/1/47 1 1 384 2
A/Swine/Shope/56 1 1 512 3
A/Duck/Alberta/35/76 1 1 768 4
A/Singapore/1/57 2 2 256 5
A/Hong Kong/1/68 3 2 512 6
A/Equine/Miami/1/63 4 8 256 7
A/Duck/Ukraine/1/63 5 8 512 8
A/Duck/Czechoslovakia/1/56 6 6 256 9
A/Tern/South Africa/61 5 3 256 10
A/Duck/Hong Kong/205/77 5 3 128 11
A/Turkey/Massachusetts/65 6 —a 512 12
A/Shearwater/Australia/1/72 6 5 192 13
A/Equine/Prague/1/56 7 7 1024 14
A/Seal/Massachusetts/1/80 7 7 128 15
A/Turkey/Ontario/6118/68 8 4 128 16
A/Turkey/Wisconsin/1/66 9 2 384 17
A/Chicken/Germany/49 10 7 384 18
A/Duck/England/1/56 11 6 256 19
A/Duck/Memphis/546/76 11 9 768 20
A/Duck/Alberta/60/76 12 5 128 21
A/Gull/Maryland/704/77 13 6 256 22
A/Mallard/Gurjev/263/82 14 — 768 23
A/Duck/Australia/341/83 15 8 256 24
A/Shearwater/West Australia/2576/79 15 9 512 25
a —, NA subtype unknown.
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bridization of dot blots with the internal biotinylated oligonu-
cleotide probe M93C also resulted in clear signals for each of
the influenza A virus strains tested.
We next compared the sensitivity of this PCR with virus
propagation in cell cultures. A stock of influenza virus A/Neth-
erlands/18/94 (H3N2) was generated in tMK cells. This virus
stock contained 107 TCID50s of influenza A virus per ml of
culture supernatant, as determined with tMK and MDCK cells
(17). Serial 10-fold dilutions of virus were made in transport
medium, and RNA was isolated for use in PCR analysis, aga-
rose gel electrophoresis, or dot blot hybridization. The ex-
pected DNA fragment of 244 bp was visible on an agarose gel
stained with ethidium bromide when the RNA equivalent of
0.2 TCID50 of influenza A virus was used as input in the PCR
(Fig. 3, lane 8). By using dot blots and hybridization, 0.02
TCID50 of influenza A virus was found to be the detection limit
of the assay (Fig. 3, lane 9, and data not shown). Similar results
were obtained with a second influenza A virus isolate, and such
results were found to be reproducible (data not shown). These
data indicate that our PCR procedure is up to 100-fold more
sensitive than virus propagation in MDCK and tMK cells.
To test the specificities of our PCR primers, RNA was iso-
lated from stocks of a number of RNA viruses, followed by
PCR amplification and gel electrophoresis or dot blot hybrid-
ization. RNA was isolated from 0.2 ml of virus stocks contain-
ing either influenza B virus, HRSV, PIV-1 through PIV-4,
simian parainfluenza virus type 5 (SV5), NDV, mumps virus,
measles virus, or Sendai virus. One-tenth of the RNA, repre-
senting the equivalent of 20 ml of virus stock ranging in titer
from 104 to 106 TCID50s/ml, was used for PCR. Upon agarose
gel electrophoresis, weak bands and smears of bands ranging
from 150 to 400 bp in length were observed after PCR ampli-
fication of some of the virus samples (PIV-1, -2, and -3, NDV,
mumps virus, and influenza B virus), presumably as a result of
nonspecific amplification of the high levels of viral RNA
present in these samples. However, upon hybridization of dot
blots with the biotinylated oligonucleotide M93C, all RNA
FIG. 1. Entropy plots of oligonucleotide-annealing sites in human and animal influenza A virus sequences available from the influenza virus sequence database. The
sequences recognized by oligonucleotides Mx1, Fam1, NS486C, Mx2, Fam2, NS637R, M52C, M253R, and M93C were compared to all available influenza A virus
sequences (n 5 189, 189, 234, 203, 204, 249, 175, 215, and 189, respectively), and their heterogeneities are displayed in panels A through I, respectively. Oligonucleotide
positions are given in the 59 to 39 direction, with position 1 being the extreme 59 nucleotide. Asterisks indicate primer positions with degeneracy in the designed
oligonucleotides. Oligonucleotides M52C, M253R, and M93C were designed in the present study.
FIG. 2. PCR analysis of the influenza A viruses, listed in Table 1, which
originated from different hosts and geographical locations. RNA was isolated
from influenza A viruses grown in embryonated chicken eggs, followed by PCR
analysis and agarose gel electrophoresis (top panels) or dot blot analysis (bottom
panels). Lanes 1 to 25, see Table 1; lane 26, negative control.
FIG. 3. Sensitivity of detection of influenza A virus RNA by PCR. RNA was
isolated from 0.2 ml of 10-fold serial dilutions of influenza virus A/Netherlands/
18/94 (107 TCID50s/ml) and was used for PCR analysis followed by agarose gel
electrophoresis and ethidium bromide staining (top panel) or dot blot analysis
(bottom panel). Lane 1, negative control; lanes 2 to 9, dilution series represent-
ing the equivalent of 2 3 105 to 0.02 TCID50s per sample. Samples containing
less than 0.02 TCID50 were negative by PCR and dot blot analysis (data not
shown).
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virus samples except for that with influenza A virus were neg-
ative (Fig. 4).
Detection of influenza A virus in human throat swab sam-
ples. Throat swab samples sent to the virus diagnostic labora-
tory at Erasmus University Medical Center are routinely tested
for the presence of influenza A virus by direct IF (DIF) and
inoculation in MDCK or tMK cell cultures in combination with
IF (7). For a selection of influenza A virus-positive throat swab
samples obtained in the 1994-1995 influenza season, influenza
A virus titers were determined by end point dilution and in-
oculation of tMK cells. A selection of influenza A virus-posi-
tive (n 5 13) and influenza A virus-negative (n 5 26) samples
was coded and tested blindly by PCR and dot blot hybridiza-
tion. All influenza A virus-positive samples, with titers ranging
from 0 to 105.75 TCID50s per ml of throat swab sample, were
positive upon agarose gel electrophoresis and dot blot hybrid-
ization (Fig. 5). One of the influenza A virus PCR-positive
samples (lane 6) tested negative upon inoculation of mamma-
lian cell cultures (hence, 0 TCID50). This sample had been
found to be influenza A virus positive by DIF with the cells
present in the throat swab sample (7), but no virus could be
isolated. Of 26 negative control samples (13 were influenza B
virus positive and 13 were influenza A and B virus negative in
mammalian cell cultures), 24 were negative upon PCR and dot
blot analyses. Two of the swabs were negative for influenza A
virus in mammalian cell culture and by IF but yielded very
weak signals after PCR and dot blot hybridization (lanes 9 and
30). These weak dot blot signals may be due to background
hybridization or the presence of very small amounts of influ-
enza A virus RNA in the throat swabs.
Detection of influenza A virus in bird samples. We next
tested the suitability of the PCR for avian influenza A virus
screening of cloacal swab and dropping samples from ducks,
geese, and shorebirds collected in The Netherlands and Swe-
den. Because PCR screening appeared to be up to 100-fold
more sensitive than virus isolation (see above) and to reduce
cost and workload, the numbers of RNA isolations and PCR
analyses were reduced by making pools of five samples each
(40 ml per sample). Between each five pooled samples, a neg-
ative control consisting of transport medium was inserted to
check for contamination during processing of the samples.
Among the 235 pools of samples representing 1,175 individual
specimens, RNA isolation, PCR, and Southern or dot blot
hybridization revealed the presence of influenza A virus in 19
of them (the results of the analysis of 38 of these pools is shown
in Fig. 6). RNA was then isolated from each of the individual
samples present in these 19 pools, revealing that all except 1
pool contained a single positive bird sample; the one exception
contained two positive samples.
Each of the 20 positive individual samples was used to in-
FIG. 4. Specificity of detection of influenza A virus RNA by PCR. RNA was
isolated from virus stocks and was used for PCR analysis and subsequent agarose
gel electrophoresis (top panel) or dot blot hybridization (bottom panel). Lanes:
1, HRSV; 2, PIV-1; 3, PIV-2; 4, PIV-3; 5, PIV-4; 6, Sendai virus; 7, SV5; 8, NDV;
9, mumps virus; 10, measles virus; 11, influenza B virus; 12, influenza A virus.
FIG. 5. PCR-based detection of influenza A virus in 39 human throat swab
samples. Throat swab samples that were tested previously for the presence of
influenza A virus by classical screening methods (7) were randomized and tested
blindly by PCR. RNA was isolated from 0.2 ml of a throat swab sample and was
used for PCR and dot blot analysis. Lanes 1, 4, 7, 8, 13, 16, 18, 23, 24, 30, 34, 35,
and 38, influenza virus-negative samples; lanes 2, 5, 9, 10, 12, 14, 15, 20, 21, 22,
25, 29, and 31, influenza B virus-positive samples; lane 40, 10 TCID50s of
influenza virus A/Netherlands/18/94 as a positive control; lanes 3, 6, 11, 17, 19,
26, 27, 28, 32, 33, 36, 37, and 39, influenza A virus-positive samples in which virus
titers determined in MDCK cells were 105.75, 0, 103.5, 102.25, 100.75, 104.25, 100.75,
103.75, 104.25, 105.25, 104.5, 105.75, and 103.5 TCID50s/ml respectively.
FIG. 6. PCR-based detection of influenza A virus in a representative set of
avian cloacal swab and dropping samples. RNA was isolated from 0.2 ml of 38
pooled samples, each consisting of five individual bird samples, and was used for
PCR and Southern blot analysis. Lanes 1, 11, 21, 31, and 41, positive controls
representing 10 TCID50s of influenza virus A/Netherlands/18/94; lanes 7, 14, 20,
27, 34, 40, and 47, negative controls; lanes 2 to 5, duck cloacal swab samples;
lanes 6, 8 to 10, 12, 13, 15 to 19, 22 to 26, and 28 to 30, goose dropping samples;
lanes 32, 33, 35 to 39, 42 to 46, and 48 to 50, goose cloacal swab samples. Each
of the pools represented in lanes 13, 15, 23, 30, 36, 39, 43, and 44 was found to
contain a single positive individual bird sample. Virus was isolated in embryo-
nated chicken eggs from samples represented in lanes 13, 15, 23, 30, 39, and 43
but not from those represented in lanes 35, 36, and 44.
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oculate two to four embryonated chicken eggs from which the
allantoic fluids were collected, pooled, and inoculated a second
time in duplicate in embryonated chicken eggs (blind passage).
For 15 of 20 PCR-positive samples we were able to isolate
influenza A virus in eggs. For the other five samples, which
appeared to contain less virus, as judged by the intensity of the
signals on dot blots (e.g., lanes 35, 36, and 44 in Fig. 6), no
influenza A virus could be isolated even upon blind passage in
embryonated chicken eggs.
To test the possibility that the PCR analysis would give
false-negative results compared to virus isolation in eggs, 243
individual PCR-negative cloacal swab and dropping samples
were inoculated into two to four embryonated chicken eggs
each, followed by a blind passage of the pooled allantoic fluids
in duplicate. We were unable to isolate influenza A virus from
these PCR-negative samples, indicating that no false-negative
results were obtained by PCR analysis. Inoculation of tMK and
MDCK cell cultures with 212 random PCR-negative individual
bird samples also did not reveal additional influenza A virus-
positive samples. In fact, these cell lines were found to be less
susceptible to avian influenza A virus than embryonated
chicken eggs were (data not shown).
DISCUSSION
PCR-based methods for virus detection have been described
for many clinically relevant viruses. The sensitivities and spec-
ificities of PCR-based methods are most critically determined
by the choice of primer sequences. The sequences of the
primer sets described earlier for PCR-based detection of in-
fluenza A virus may be appropriate for the detection of virus
strains currently circulating in humans (1, 3, 6, 7) but display
considerable numbers of mismatches when they are compared
with the sequences of animal influenza A viruses. We have
used an extensive amount of the sequence information avail-
able for influenza A virus to design a new PCR primer set for
diagnostic purposes. Primers M52C and M253R and probe
M93C span conserved sequences in gene segment 7 of influ-
enza A virus and have no homology to nucleotide sequences
from other species available from GenBank (http://www
.ncbi.nlm.nih.gov). Our experimental data confirmed that PCR
amplification and dot blot analyses with this set of primers does
not pick up cross-reacting host-derived sequences or other
RNA viruses and is suitable for detection of a wide variety of
influenza A virus strains. The limited variability in influenza A
virus sequences spanning the primer sequences is mostly con-
fined to the 59 ends of the oligonucleotides and therefore is
unlikely to obscure PCR amplification. Indeed, we successfully
amplified the genomes of virus isolates with mismatches in
these primer sequences that were included in the viruses shown
in Table 1 and Fig. 2.
On the basis of the results of titration experiments as well as
on analyses of clinical specimens, we conclude that the PCR-
based method is more sensitive (up to 100-fold) than virus
isolation in eggs or mammalian cell cultures. This is not sur-
prising in view of the sensitivity of PCR-based assays in general
and the low ratio of infectious units to physical particles for
RNA viruses such as influenza A virus. Perhaps as a result of
the high sensitivity, we detected influenza A virus in a human
throat swab sample from which no virus could be isolated.
Individual cells isolated from this throat swab sample were
positive upon DIF analysis, confirming influenza A virus infec-
tion.
An additional advantage of the PCR-based method is its
value in the identification of influenza A viruses from different
species. Because of differences in cellular tropism between
avian, human, and swine influenza A viruses, a single cell type
for virus isolation for diagnostic purposes is not available.
Continuous and primary cell lines obtained from a variety of
animal species and embryonated chicken eggs are routinely
used for isolation of influenza A viruses. Using the PCR-based
method, we have detected many influenza A viruses in bird
samples that could not be isolated in mammalian cell cultures
and some that could not be isolated in embryonated chicken
eggs. Presumably, this failure was due to a combination of low
virus titers in the original specimens and the limited suscepti-
bilities of the target cells to certain influenza A virus strains. As
a national influenza center, we occasionally receive specimens
from humans from which no virus can be isolated in mamma-
lian cell cultures but that are readily found to be influenza A
virus positive by this PCR approach (data not shown).
One disadvantage of PCR-based assays is that it is difficult to
assess if weak positive PCR results (e.g., Fig. 5, lanes 9 and 30,
and Fig. 6, lanes 35, 36, and 44) are the result of background
hybridization or low virus titers in the original samples because
of the lack of confirmation assays that are as sensitive as PCR-
based methods. Therefore, it is of great importance that suf-
ficient negative controls be included to determine a cutoff
value for background hybridization. In addition, we routinely
use 10-fold serial dilutions of a titrated influenza A virus stock
as input material in our PCR-based assays to provide a semi-
quantitative estimate of variability between independent as-
says. Both sets of controls will aid in the determination of a
cutoff value for background hybridization and weak positive
samples.
By PCR-based assays, diagnosis of influenza A virus infec-
tion can be achieved within a single working day, which is
significantly faster than the time to diagnosis of infection by
classical methods. By virus culture approaches, positive results
may be obtained in 24 h or more after inoculation, but a
definite negative diagnosis may require culture for up to 2
weeks. The availability of NA inhibitors for the treatment of
influenza virus infection may demand more rapid diagnosis of
virus infection in the future. The benefit of these new drugs
appears to depend heavily on the early start of treatment, i.e.,
within 2 days after the onset of disease (11).
Taken together, our data indicate that the newly designed
PCR offers a more sensitive and faster tool for the diagnosis of
human influenza A virus infection than virus isolation. Because
of the better matching primers, it can be expected that for the
detection of animal influenza A viruses this PCR is also more
suitable than previous PCR protocols (1, 3, 7).
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